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Abstract Mesenchymal stem cells (MSC) are multipotent
cells which can be obtained from several adult and fetal
tissues including human umbilical cord units. We have
recently shown that umbilical cord tissue (UC) is richer in
MSC than umbilical cord blood (UCB) but their origin and
characteristics in blood as compared to the cord remains
unknown. Here we compared, for the first time, the exonic
protein-coding and intronic noncoding RNA (ncRNA)
expression profiles of MSC from match-paired UC and
UCB samples, harvested from the same donors, processed
simultaneously and under the same culture conditions. The
patterns of intronic ncRNA expression in MSC from UC
and UCB paired units were highly similar, indicative of their
common donor origin. The respective exonic protein-coding
transcript expression profiles, however, were significantly
different. Hierarchical clustering based on protein-coding
expression similarities grouped MSC according to their tissue
location rather than original donor. Genes related to systems
development, osteogenesis and immune system were
expressed at higher levels in UCB, whereas genes related to
cell adhesion, morphogenesis, secretion, angiogenesis and
neurogenesis were more expressed in UC cells. These
molecular differences verified in tissue-specific MSC gene
expression may reflect functional activities influenced by
distinct niches and should be considered when developing
clinical protocols involving MSC from different sources. In
addition, these findings reinforce our previous suggestion on
the importance of banking the whole umbilical cord unit for
research or future therapeutic use.
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Abbreviations
MSC Mesenchymal stem cells
HSC Hematopoietic stem cells
UC Umbilical cord
UCB Umbilical cord blood
BM Bone marrow
Introduction
Multipotent mesenchymal stem cells (MSC) are an imma-
ture cell type with ability to self-renew and differentiate
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into specific functional cell types including chondrocytes,
osteocytes, adipocytes, myocytes, and neurons. Phenotypic
and genetic lines of evidence suggest that MSC are a useful
model for developmental biology studies in normal and
disease backgrounds, in addition to their therapeutic
potential [1–4].
MSC were originally isolated from bone marrow (BM).
Subsequently, similar populations have been reported in
other tissues, such as adipose tissue [5, 6], dental pulp [7],
placenta, umbilical cord blood (UCB) and umbilical cord
tissue (UC), as well as from a variety of fetal tissues, such as
spleen, lung, pancreas, kidney, and amniotic fluid during
midgestation [8–13]. According to some authors, MSC are
located in the vascular wall, constituting a MSC compart-
ment extending throughout the entire organism [14–18]. In
fact, it is known that many tissues contain lineage-committed
progenitor cells for their maintenance and repair and several
studies have demonstrated the presence of uncommitted
MSC within the perivascular niche of several organs in
animal models, where their function is to stabilize blood
vessels, and to contribute to tissue homeostasis [19–21]. On
the other hand, MSC seem to be absent from the circulating
blood under normal physiological conditions [17, 22] and
their presence in term UCB is controversial; some research-
ers successfully isolated MSC from UCB [10, 23–25],
whereas others failed or obtained cells at low yield [11, 22,
26, 27]. We have recently shown that UC is much richer in
MSC than UCB [11]. However, the question of whether the
cells obtainable from both compartments were actually the
same entity or not remained unanswered.
Several studies based on protein-coding gene expression
profiling have been conducted with the aim of enhancing
our understanding on MSC biology and ontogeny [28–33].
Further, recent investigation has demonstrated that non-
coding RNAs, in addition to protein-coding genes, encom-
pass several functions related to stem cell biology,
including the maintenance of pluripotency and induction
of cellular differentiation programs [34]. Given their
presence in other cell-types and tissue, the noncoding
transcripts are likely to be involved in other aspects of
mammalian developmental and cellular biology [34–38].
More specifically, there are already a few examples of
cellular mechanisms involving noncoding RNAs such as:
an antisense noncoding RNA regulating usage of alterna-
tively spliced isoforms of the Fas protein-coding gene
transcribed from the same locus [39]; an antisense non-
coding RNA regulating translation of the host PU.1
protein-coding gene [40]; and an intronic noncoding RNA
from the CFTR locus regulating the expression of genes for
specific cellular processes related to the function of the
CFTR protein-coding gene [41].
Considering that large-scale expression studies are
commonly restricted to protein-coding genes [28–33],
studying the new and expanding class of noncoding RNA
transcripts in a genome-wide scale is of great interest and
may enhance our understanding of their biological func-
tions in MSC.
Here, we analyzed, for the first time, the exonic protein-
coding and intronic noncoding RNA expression profiles
from match-paired UCB and UC samples, which were
harvested from the same donors, processed simultaneously,
and kept under the same culture conditions. The intronic
noncoding RNA expression pattern of MSC from UC and
UCB paired samples were highly similar suggesting that
they share a common cellular origin. Surprisingly, we found
significant differences in the global exonic protein-coding
transcript expression patterns of MSC from UCB and UC
paired samples, suggesting tissue specificity. These findings
provide new insights on the biology and ontogeny of MSC
in vivo, and add new information to be considered when
developing clinical protocols involving MSC obtained from
different sources.
Materials and Methods
Harvesting of UC and UCB
Sixty-five human UC and UCB matching units were
collected after informed consent from all mothers and in
accordance with the ethical committee of Jesus, José e
Maria Hospital, University Hospital and Institute of
Bioscience of University of São Paulo.
UCB was harvested from each sample, and conserved with
100mMEDTA anticoagulant at 22°C. Sections of 8–10 cm of
umbilical cords, which are routinely discarded, were internally
washed with phosphate-buffered saline (PBS), supplemented
with 3% penicillin/streptomycin (Invitrogen-Gibco, Grand
Island, NY, http://www.invitrogen.com) and immediately
immersed in Dulbecco’s modified Eagle’s medium-low
glucose (DMEM-LG; Invitrogen-Gibco) supplemented with
10% fetal bovine serum (FBS; Invitrogen-Gibco) and 3%
penicillin/streptomycin (Invitrogen-Gibco). All samples were
processed within 12–15 h after collection.
Isolation and Culture of Adherent Cells from UCB and UC
After blood dilution of 3:1 with RPMI 1640 medium
(Invitrogen-Gibco), mononuclear cells (MNCs) were isolated
by density gradient centrifugation at 400 x g for 30 min at
room temperature (25°C) using Ficoll-Paque Premium (GE
Healthcare, Little Chalfont, U.K., http://www.gehealthcare.
com). MNCs were washed twice with PBS and resuspended
in proliferation medium consisting of DMEM-LG, 10%
FBS, 100 U/ml penicillin and 1% penicillin/streptomycin.
Cells were plated at a density of 5×107 cells per ml in
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culture flasks (25 cm2) and maintained at 37°C in a
humidified atmosphere containing 5% CO2.
UCs were filled with 0.1% collagenase (Sigma-Aldrich,
St. Louis, http://www.sigmaaldrich.com/sigma-aldrich/
home.html) in PBS and incubated at 37°C for 20 min.
Each UC was washed with proliferation medium, and the
detached cells were harvested after gentle massage of the
UC. Cells were centrifuged at 300 g for 10 min, resus-
pended in proliferation medium, and seeded in 25-cm2
flasks at a density of 5×107 cells per ml.
After 24 h of incubation, non-adherent cells were
removed, and culture medium was replaced every 3 days.
Immunophenotyping
To analyze cell-surface expression of typical protein markers,
adherent cells were incubated with the following anti-human
primary antibodies: CD29-PECy5, CD34-PerCP, CD31-
phycoerythrin (PE), CD45-fluorescein isothiocyanate (FITC),
CD90-R-PE, CD73-PE, CD13-PE, CD44-PE, CD117-PE,
human leukocyte antigen (HLA)-ABC-FITC, HLA-DR-R-PE
(Becton, Dickinson and Company, Franklin Lakes, NJ, http://
www.bd.com). A total of 10,000 labeled cells were analyzed
using a Guava EasyCyte flow cytometer running Guava
ExpressPlus software (Guava Technologies Hayward, CA,
http://www.guavatechnologies.com).
Cell Differentiation Procedures
To evaluate MSC properties, adherent cells (third passage,
at 80–90% confluence) were subjected to adipogenic,
chondrogenic, and osteogenic differentiation in vitro,
according to established protocols [4, 11].
RNA Preparation
At 90% confluence, the MSC from four UC tissues and
UCB paired samples (n=4),at the second passage, were
briefly rinsed with ice-cold PBS and lysed in TRIZOL
reagent (Invitrogen, Carlsbad, CA, http://www.invitrogen.
com) for RNA extraction. RNA purification and treatment
with DNase I was performed in the ‘on-column DNase
digestion’, according to protocol of the Qiagen RNeasy kit
(Qiagen, Valencia, CA, USA). All RNA samples were
checked for purity using a ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA) and for
integrity by electrophoresis on a 2100 BioAnalyzer (Agilent
Technologies, Santa Clara, CA, USA).
Sample Labeling and Microarray Hybridization Procedures
Cy5- and Cy3-labeled cRNAs were obtained using 300 ng
total RNA as template for amplification of poly(A) RNA by
T7-RNA polymerase with the Agilent Low RNA Input
Fluorescent Linear Amplification kit. The T7-polymerase
amplified cRNA labeling approach advantageously replaces
the reverse-transcriptase cDNA labeling used in early
microarray experiments, because T7-RNA polymerase
labeling of cRNA preserves the strand orientation of the
original mRNA template. Reverse-transcriptase labeling
can eventually generate a complementary cDNA second
strand and cause artifactual labeling of a target with the
opposite sense to that of the original message.
Hybridization of 825 ng of Cy3- or Cy5-labeled RNA
(dye swap technical replicate) from each UC sample with
its paired UCB sample was performed with Agilent in situ
Hybridization kit-plus, as recommended by the manufac-
turer, using a total of 4 intron-exon 44K expression
oligoarrays. This array comprises a total of 13,699 exonic
probes representing different protein-coding genes, along
with custom-designed intronic probes for the antisense or
sense strand, as illustrated in Supplemental Figure 1 [37]
(Figure S1).
Slides were washed and processed according to the
Agilent Two-Color Microarray-Based Gene Expression
Analysis protocol (Version 5.5) and scanned on a GenePix
4000B scanner (Molecular Devices, Sunnyvale, CA, USA).
Fluorescence intensities were extracted using Feature
Extraction (FE) software (version 9.0; Agilent). A gene
was considered expressed if its probe intensity was
significantly higher than the local background intensity, as
calculated by the FE software. Then, the software applies
local background subtraction and corrects for unequal dye
incorporation using the default LOWESS (locally weighted
linear regression) method. We have included into further
statistical analyses only those genes that were detected as
expressed in at least all UC samples or all CB samples as
described below.
Microarray data has been deposited at the GEO database.
The platformAccess number is GPL9193 and the experimental
series Access number is GSE18134.
Statistical Analyses of Expression
In order to identify differentially expressed transcripts
between UC and UCB samples, we employed the Statistical
Analysis of Microarray (SAM) approach [42] (http://www-
stat.stanford.edu/tibs/SAM/), using the following parameters:
one-class analysis, 256 permutations, automatic K-Nearest
Neighbors Imputer and a significance cutoff at 5% False
Discovery Rate. We performed a detailed functional anno-
tation and description of the top 30 genes that were most
significantly over-expressed in MSC from UC or UCB. To
generate this list we started with the differentially expressed
genes determined by the SAM analysis, ranked them by
significance (q-value) and subsequently by fold change, and
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we further eliminated the eventual duplicate probes for the
same locus; the resulting two lists contain the 30 unique
protein-coding genes over-expressed in MSC from either UC
or UCB.
The set of differentially expressed protein-coding genes
was further annotated by Gene Ontology (GO) terms and
over-representation in functional categories was analyzed
by hypergeometric distribution with the Benjamini-
Hochberg correction for multiple testing (p≤0.05) using
the eGOn tool [43]. Canonical pathways enrichment
analyses of differentially expressed genes were performed
using the Ingenuity Pathway Analysis (IPA) software
(Ingenuity Systems, Redwood City, CA). This software
uses a numerical value to rank the canonical pathways
according to how relevant they are to the genes in the input
dataset. The value is calculated taking into account the
number of focus genes in the pathway and the size of the
pathway in order to approximate how relevant this pathway
is to the original list of focus genes. The significance value
(p≤0.05) is computed using the right-tailed Fisher’s Exact
Test and the p-value is corrected for multiple testing with
the Benjamini-Hochberg method. The canonical pathway
identified as significantly enriched (p<0.05) is then
presented as a graph indicating the molecular relationships
between genes/gene products.
Using the SAM approach with the same parameters
mentioned above, we found a very small number of intronic
noncoding genes with statistically significant differential
expression between UC and UCB samples (see Results).
Therefore, in this case we chose to look for over-
representation of GO functional categories and of enriched
functions among the top 33% most highly expressed
intronic noncoding RNAs in each sample. For this purpose,
each intronic noncoding transcript was functionally anno-
tated according to the protein-coding gene of the same
genomic locus and further classified by Gene Ontology
terms.
Real-Time Quantitative Polymerase Chain Reaction
Analysis
Differential expressions observed by microarray analysis
were verified by Real-time Quantitative Polymerase Chain
Reaction Analysis (RT-Q-PCR) for 7 differentially regulat-
ed genes and 1 housekeeping gene. Total RNA samples
were reverse transcribed into cDNA using Superscript III
reverse transcription kit (Invitrogen) and quantitative real-
time PCR was performed using 1 µg of cDNA and SYBR
Green PCR master mix in an ABI Prism 7500 system
(Applied Biosystems). Authenticity of the PCR products
was verified by melt-curve analysis and agarose gel
electrophoresis. Amplification efficiency of PCR products
was determined by calculating the slope after semi-
logarithmic plotting of the values against cycle number.
Samples were run in triplicates, and the threshold suggested
by the instrument software was used to calculate Ct.
Differential expression was calculated in relation to
GAPDH. Data were analyzed statistically by Mann-
Whitney test at a 0.05 level of significance. Primer
sequences are provided in Supplemental Table 1 (Table S1).
Results
Isolation and Characterization of MSC from UC and UCB
MSC could be isolated from all 65 UC samples (100%), but
only from 6 out of 65 UCB samples (9%). Previously, we
had reported that the efficiency in isolating MSC from UCB
stands around 10% [11].
All isolated MSC populations displayed a spindle-
shaped morphology (Fig. 1b, d). To evaluate MSC
properties, their immunophenotype and differentiation
capacity were considered. A panel of surface markers was
tested by flow cytometry. MSC from all paired samples
were negative for CD31 (endothelial cell marker), CD34,
CD45, CD117 (hematopoietic cell markers), and HLA-DR
(human leukocyte differentiation antigen class II), whereas
they were positive for CD29, CD44 (adhesion markers),
CD90, CD73, CD13 (mesenchymal markers), and HLA-
ABC (human leukocyte differentiation antigen class I;
Fig. 1a, c; Table 1). In vitro differentiation analysis
confirmed that all isolated MSC from each matching units
exhibited a comparable capacity to differentiate into
osteoblasts, chondrocytes and adipocytes thus confirming
their multipotent potential (Fig. 1e).
Large-Scale Gene Expression Measurements in UC
and UCB Paired Samples
The observation that both populations of cells exhibit
comparable properties and differentiation capacity, character-
istic of MSC, does not exclude the possibility that they may
differ in their potential to originate different cell lineages. To
further evaluate how similar were MSC from UCB and UC
paired samples, we examined their respective gene expression
profiles (n=4) using the 44 k intron-exon oligoarray
previously designed by our group [37].
A total of 38,960 probes are present in the oligoarray,
comprising probes for exons of 13,699 protein-coding
transcripts, along with 7,515 pairs of probes for totally
intronic noncoding (TIN) transcripts, both for the sense
(S-TIN) and anti-sense (AS-TIN) strands, plus 4,920 probes
for antisense partially intronic noncoding (AS-PIN) tran-
scripts (Table 2). The term AS-PIN is used to identify a
transcript that overlaps an exon and is transcribed from the
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opposite strand extending at least 30 bases into the adjacent
introns over both ends of the exon [37] (Figure S1).
A total of 10,935 exonic, 1,645 AS-TIN, 2,651 AS-PIN
and 2,420 S-TIN transcripts were found to be expressed in
UCB and UC samples (Table 2) and were further analyzed
for differential expression as described in the next section.
Reproducibility in the microarray experiments was
assessed by dye swap technical replicate using separately
Fig. 1 Characterization of adherent cells isolated from UCB and UC. a,
c Flow cytometric analysis of cell surface markers of MSC from UCB
and UC, respectively. Representative histograms are demonstrated, and
their respective controls are shown by the black lines. b, d Morphology
of adherent cells isolated from UCB and UC. After 15 days in culture,
all isolated MSC populations displayed a spindle-shaped morphology. e
Differentiation potential of adherent cells isolated from UCB and UC.
Osteogenic differentiation of adherent cells from UCB and UC was
demonstrated by calcium deposition shown by von Kossa stain;
Adipogenesis was detected by the formation of intracytoplasmic lipid
droplets stained with oil red O; Cell spheres from UCB and UC were
stained with toluidine blue to confirm chondrogenic differentiation.
Mucopolysaccharide-rich extracellular matrix is shown in pinkish
metachromatic areas. Abbreviations: CD cluster of differentiation;
HLA-ABC human leukocyte antigen-ABC; HLA-DR human leukocyte
antigen-DR; UCB umbilical cord blood; UC umbilical cord
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prepared target RNA from each MSC sample. The
correlation coefficient between two microarray datasets
obtained from repeated experiments was greater than 0.98,
indicating that not only each microarray system per se, but
also the overall experimental procedures were highly
reproducible (Figure S2).
Protein-Coding Expressed Transcripts
The entire set of expressed protein-coding genes was used
for a non-supervised hierarchical clustering analysis. The
dendrogram in Fig. 2a evidences that MSC isolated from
the same tissue (UC or UCB) clustered together, while
MSC from different tissues of the same donor were found
in different clusters.
These results indicated that gene expression profiles of
MSC from the same tissue were more similar than those of
MSC obtained from different tissues (UC versus UCB) of the
same donor, suggesting the existence of a core gene
expression profile for the MSC from each tissue, independent
of the inter-donor differences.
In order to determine the statistical significance of such
patterns, correlation coefficients were calculated for all
possible combinations of expression measurements and a
Student t-test was applied, as described below. Considering
the exonic probes for protein-coding genes, the correlation
coefficient among UC samples was in the range 0.899 to
0.972 (Table 3A, Figure S3 A). A similar trend was observed
in the UCB group, where the correlation coefficient was in
the range 0.901 to 0.955 (Figure S3 D). In contrast, the
correlation coefficient between paired UC versus UCB MSC
samples from the same individuals (for example, UC1 versus
UCB1) was in the range 0.837 to 0.925 (Figure S3 B, C).
The correlation coefficient for comparisons within UC
samples (Table 3A) was significantly higher than the
correlation for comparisons between UC versus UCB within
the same individual (p=0.026) (Table 3A). A similar trend
was observed for the UCB samples, although this difference
was not statistically significant (p=0.067) (Table 3A).
Differential Gene Expression of Protein-Coding Genes
in UC and UCB Tissues
To identify the individual gene expression signature of each
group of MSC, we used a one-class paired analysis with the
SAM statistical approach (Fig. 3).
A total of 1,054 different protein-coding genes were
expressed at significantly higher levels in MSC from UC
while 816 genes were significantly higher in MSC from
UCB (Table 2). The full list of differentially expressed
genes is shown in Supplemental Table 2 (Table S2).
Table 2 Protein-coding and noncoding genes expressed in MSC from UC and UCB tissues
Exonic Intronic All ncRNAs
probes % AS-TIN S-TIN AS-PIN Other ncRNA
probes % probes % probes % probes % probes %
On the Array 13699 100 7515 100 7515 100 4920 100 662 100 20612 100
Expressed in UC and UCB 10935 80 1645 22 2420 32 2651 54 454 69 7170 35
probes %a probes %a probes %a probes %a probes %a probes %a
Over-expressed in UC (FDR 5%) 1054 10 30 2 68 3 118 5 18 4 234 3
Over-expressed in UCB (FDR 5%) 816 8 25 2 124 5 51 2 19 4 219 3
Total differentially expressed 1870 18 55 4 192 8 169 7 37 8 453 6
UCB umbilical cord blood; UC umbilical cord
a Percent over-expressed probes is calculated in relation to the total number of probes of this category that are expressed in UC and UCB
Table 1 Summary of surface markers expression in MSC from UCB
and UC
Surface Marker UCB (%) UC (%)
Control 0.84 0.98
CD 13 98.18 96.64
CD 29 97.88 97.94
CD 44 97.72 97.18
CD73 98.26 98.84
CD 34 1.46 3.26
CD 45 1.10 4.54
CD 117 1.88 1.38
CD 31 1.22 1.28
HLA-ABC 93.10 99.82
HLA-DR 1.68 1.94
Data represent the mean of 3 different samples (n=3). The results
showed are percentage of positive cells
HLA-ABC human leukocyte antigen-ABC; HLA-DR human leukocyte
antigen-DR; UC umbilical cord; UCB umbilical cord blood
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Functional Annotation of Protein-Coding Genes
Over-Expressed in MSC from UC
Genes that were found to be over-expressed in MSC from
UC were functionally annotated and analyzed with two
different tools. First, enriched gene ontology (GO) terms
were identified with the eGOn tool. A statistically significant
over-representation of genes involved in morphogenesis, cell
adhesion and secretion GO categories were identified
(Table S3).
Next, the Ingenuity Pathway Analysis (IPA) software
was used for identifying canonical pathways that were
significantly enriched. We found that the “Synaptic Long
Term Depression” pathway was significantly over-
represented (adjusted p-value = 0.042). A total of 17 genes
out of 139 genes in this pathway were found to be over-
expressed in MSC from UC. A scheme of the pathway
(Figure S4) and the full list of genes involved (Table S4)
are shown.
Fig. 2 Non-supervised hierarchical clustering of a all 10,935 protein-
coding genes and b all 7,170 intronic noncoding RNAs, expressed in
MSC from UC and UCB. Each row represents the relative levels of
expression for a single gene, calculated as the number of standard
deviations above (red) or below (green) the mean expression level of
that gene across the samples. Each column represents the average
expression of two technical replicate (Cy3 and Cy5) measurements of
each sample. In a MSC isolated from the same tissue clustered together
while MSC from different tissues (UC or UCB) and same donors are
found in different clusters. In bMSC isolated from different tissues (UC
or UCB) and the same donor clustered together while MSC from the
same tissue and different donors are found in different clusters
Fig. 3 Expression signature of protein-coding transcripts in MSC
from UC and UCB. A total of 1,870 genes with significantly different
levels among MSC from UC and UCB samples were identified by
SAM one-class statistical analysis (FDR < 5%) and hierarchically
clustered as described in Materials and Methods. Each row represents
the relative levels of expression for a single gene, calculated as the
number of standard deviations above (red) or below (green) the
average expression level of that gene across the samples. Each column
represents the average expression of two technical replicate (Cy3 and
Cy5) measurements of each sample
r2 within same tissue UC vs UCB p-value
r2 within same donor
A) Protein-coding gene expression: analysis of correlations between MSC from UC and UCB
UC 0.94±0.025 0.89±0.041 0.026
UCB 0.92±0.019 0.89±0.041 0.067
B) Noncoding gene expression: analysis of correlations between MSC from UC and UCB
UC 0.98±0.005 0.99±0.006 0.060
UCB 0.98±0.007 0.99±0.006 0.029
Table 3 Correlation coefficients
(r2) among expression profiles
Data shown are mean ± SD from
r2 values within each group (r2
data from Figure S5)
UCB umbilical cord blood; UC
umbilical cord
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Further, we ranked genes by significance (SAM q-value)
and chose the top 30 genes that were significantly more
expressed in MSC from UC (Table 4). The over- expressed
genes in MSC from UC included genes involved in
neurogenesis, such as SYNPO2 (synaptoidin) and NRP2,
and angiogenesis, such as FLT1 (vascular endothelial
growth factor-VEGF).
Functional Annotation of Protein-Coding Genes Over-
Expressed in MSC from UCB
Using a method similar to the aforementioned analysis of
MSC from UC, we examined the gene expression profile of
MSC from UCB. Gene ontology analysis revealed a
significantly higher representation of genes involved in
anatomical structure development and multicellular organ-
ism development (Table S3). Using the Ingenuity Pathway
Analysis (IPA) tool we could not find any significantly
over-represented canonical pathway.
Among the top 30 genes that were significantly more
expressed in MSC from UCB there were genes
involved in osteogenesis, such as SPP1 (secreted
phosphoprotein 1, osteopontin) and POSTN (periostin,
osteoblast specific factor) (Table 5), and development of
B-lymphoid cells, such as EBF1 and EBF3 (early B-cell
factor 1, 3).
Table 4 Top 30 over-expressed protein-coding genes in MSC from UC
Overexpressed in UC






139065 SLITRK4 Xq27.3 SLIT and NTRK-like family, member 4 0 126.1
590 BCHE 3q26.1-q26.2 butyrylcholinesterase 0 88.4
10580 SORBS1 10q23.3-q24.1 sorbin and SH3 domain containing 1 0 57.8
10788 IQGAP2 5q13.3 IQ motif containing GTPase activating protein 2 0 53.4
2321 FLT1 13q12 fms-related tyrosine kinase 1 (vascular endothelial
growth factor/vascular permeability factor receptor)
0 52.7
9699 RIMS2 8q22.3 regulating synaptic membrane exocytosis 2 0 27.2
7980 TFPI2 7q22 tissue factor pathway inhibitor 2 0 25.7
25849 DKFZP564O0823 4q13.3-q21.3 DKFZP564O0823 protein 0 25.4
753 C18orf1 18p11.2 chromosome 18 open reading frame 1 0 23.8
171024 SYNPO2 4q26 synaptopodin 2 0 21.1
57110 HRASLS 3q29 HRAS-like suppressor 0 19.9
144100 PLEKHA7 11p15.1 pleckstrin homology domain containing, family
A member 7
0 19.0
244 ANXA8 10q11.2 annexin A8 0 17.4
1803 DPP4 2q24.3 dipeptidyl-peptidase 4 (CD26, adenosine deaminase
complexing protein 2)
0 16.8
55691 FRMD4A 10p13 FERM domain containing 4A 0 16.1
121551 BTBD11 12q23.3 BTB (POZ) domain containing 11 0 16.1
50507 NOX4 11q14.2-q21 NADPH oxidase 4 0 15.1
6653 SORL1 11q23.2-q24.2 sortilin-related receptor, L(DLR class) A repeats-
containing
0 14.9
158038 LRRN6C 9p21.2-p21.1 leucine rich repeat neuronal 6C 0 14.7
22998 DKFZP686A01247 4p13 hypothetical protein 0 11.3
104 ADARB1 21q22.3 adenosine deaminase, RNA-specific, B1 (RED1
homolog rat)
0 11.2
7163 TPD52 8q21 tumor protein D52 0 11.0
23555 TSPAN15 10q21.3 tetraspanin 15 0 10.7
55022 FLJ20701 2q36.3 hypothetical protein FLJ20701 0 9.4
8828 NRP2 2q33.3 neuropilin 2 0 9.3
54361 WNT4 1p36.23-p35.1 wingless-type MMTV integration site family, member 4 0 9.3
256435 ST6GALNAC3 1p31.1 1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 0 9.3
5924 RASGRF2 5q13 Ras protein-specific guanine nucleotide-releasing factor 2 0 9.1
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Partially and Totally Intronic Noncoding Transcripts
Expressed in UC and UCB Paired Samples
Table 2 shows the number of protein-coding and intronic
noncoding probes expressed in all UCB and UC samples.
While 80% of protein-coding messages were expressed,
only 22% of antisense TIN, 54% of antisense PIN and 32%
of sense TIN transcripts were expressed in the tissues. This
reveals that the diversity of intronic noncoding messages
was lower than that of protein-coding messages.
We looked at the overall pattern of noncoding expression
using a non-supervised hierarchical clustering (Fig. 2b).
One can see that the MSC isolated from different tissues of
the same donor clustered together while MSC from the
same tissue and different donors were found in different
clusters, thus suggesting that the intraindividual intronic
noncoding expression profile was less variable between
MSC from UC versus UCB than among the individuals.
The correlation coefficients between the UC and UCB
paired samples from the same donor were in the range 0.979–
0.989 (Figure S5 B, C), while the correlation coefficients
among the UCB samples from different donors were in the
range 0.963–0.991 (Figure S5 A), and among UC samples in
the range 0.967–0.987 (Figure S5 D). Table 3B shows that
the average correlation coefficient between UC versus UCB
of the same donors was significantly higher (p=0.029) than
the average correlation coefficient among MSC from UCBs
of different donors. A similar comparison with the average
Table 5 Top 30 over-expressed protein-coding genes in MSC from UCB
Overexpressed in UC








84302 C9orf125 9q31.1 chromosome 9 open reading frame 125 0 51.5
81578 COL21A1 6p12.3-p11.2 collagen, type XXI, alpha 1 0 40.0
3679 ITGA7 12q13 integrin, alpha 7 0 28.1
79614 C5orf23 5p13.3 chromosome 5 open reading frame 23 0 25.7
2044 EPHA5 4q13.1 EPH receptor A5 0 25.0
2006 ELN 7q11.23 elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) 0 23.9
7373 COL14A1 8q23 collagen, type XIV, alpha 1 (undulin) 0 23.9
10631 POSTN 13q13.3 periostin, osteoblast specific factor 0 22.3
5168 ENPP2 8q24.1 ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) 0 16.7
5137 PDE1C 7p15.1-p14.3 phosphodiesterase 1C, calmodulin-dependent 70kDa 0 15.3
8839 WISP2 20q12-q13.1 WNT1 inducible signaling pathway protein 2 0 15.2
183 AGT 1q42-q43 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 0 14.4
8490 RGS5 1q23.1 regulator of G-protein signalling 5 0 13.9
182 JAG1 20p12.1-p11.23 jagged 1 (Alagille syndrome) 0 13.1
1879 EBF1 5q34 early B-cell factor 1 0 12.5
253738 EBF3 10q26.3 early B-cell factor 3 0 12.3
2012 EMP1 12p12.3 epithelial membrane protein 1 0 11.7
6696 SPP1 4q21-q25 secreted phosphoprotein 1 (osteopontin, bone sialoprotein I,
early T-lymphocyte activation 1)
0 10.9
23136 EPB41L3 18p11.32 erythrocyte membrane protein band 4.1-like 3 0 10.7
3983 ABLIM1 10q25 actin binding LIM protein 1 0 10.5
3783 KCNN4 19q13.2 potassium intermediate/small conductance calciumactivated
channel, subfamily N, member 4
0 10.2
342184 FMN1 15q13.3 formin 1 0 10.1
5328 PLAU 10q24 plasminogen activator, urokinase 0 9.2
130916 MTERFD2 2q37.3 MTERF domain containing 2 0 8.6
9510 ADAMTS1 21q21.2 ADAM metallopeptidase with thrombospondin type 1 motif, 1 0 8.5
9783 RIMS3 1pter-p22.2 regulating synaptic membrane exocytosis 3 0 7.9
57520 HECW2 2q32.3-q33.1 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 0 7.9
4629 MYH11 16p13.11 myosin, heavy chain 11, smooth muscle 0 7.8
255488 IBRDC2 6p22.3 IBR domain containing 2 0 6.8
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correlation coefficient among MSC from UCs of different
donors showed the same trend, although the difference was
not statistically significant (p=0.060) (Table 3B). The
statistical analysis of correlation coefficients showed that
the intronic noncoding expression profile was almost
invariable among the individuals and even less variable
between MSC from UC versus UCB of the same donor.
Using the same statistical significance analyses, a total of
4% expressed antisense PIN, 7% antisense TIN and 8%
sense TIN transcripts were detected as differentially
expressed between UC and UCB paired samples, while
18% protein-coding transcripts were detected as differen-
tially expressed in these samples (Table 2). This indicates
that the tissue signature of intronic noncoding expression
was more similar than the protein-coding messages between
the UC and UCB paired samples.
Functional Annotation of ncRNA Over-Expressed in MSC
from UCB and UC
The top 33% most highly expressed TIN transcripts in each
group of MSC (Table S5) were functionally annotated using
Gene Ontology terms. The only statistically significant
(adjusted p-value = 0.048) enriched GO categories in MSC
from UC comprise genes involved in transcription, includ-
ing regulation of transcription, regulation of transcription-
DNA dependent, regulation of RNA metabolic process and
biopolymer biosynthetic process (Table S6). The same GO
categories were the most enriched ones in MSC from UCB,
although this over-representation was not statistically
significant (adjusted p-value = 0.153) (Table S6).
Next, the Ingenuity Pathway Analysis (IPA) software
was used for identifying functions that were significantly
enriched among the top 33% most highly expressed TIN
transcripts in MSC from UC and UCB. Functions related to
Lymphoid Tissue Structure and Development, Cellular
Development and Organ Development were shared be-
tween the samples from UC and UCB, while Visual System
Development and Function was only enriched in UC. The
entire list of identified functions and the genes involved are
shown in Supplemental Tables 7 and 8 (Tables S7 and S8).
Validation of Microarray Results with Real-Time
Quantitative PCR
Reproducibility of our microarray results has been shown to
be fairly high [37] (Figure S2). Nevertheless, we have
selected seven differentially expressed genes between UC
and UCB samples and assessed their expression levels in
8 UC and 6 UCB units through RT-Q-PCR. Genes analyzed
were significantly differentially expressed between UC and
UCB samples (p≤0.05; Figure S6). The results were
entirely consistent with DNA microarray data. Therefore,
based on these results, we opted not to exhaustively
reanalyze all genes of interest with RT-Q-PCR. In fact,
recent microarray validation studies [44] have shown that
the Agilent oligoarray technology, used in the present study,
has been optimized to attain reproducible results.
Discussion
MSC are Isolated at Higher Yields from UC Compared
with UCB
MSC have been defined by their plastic adherent growth and
subsequent expansion under specific culture conditions, in
addition to their in vitro differentiation potential into several
cell types. Previous reports indicate that MSC can be found
in perivascular niches of several organs [14–18] but they
seem to be absent from the circulating blood under normal
physiological conditions [17, 22]. However, their presence
in UCB is controversial: some researchers successfully
isolated MSC from UCB [23–25, 45], whereas others failed
to isolate them or obtained a low yield [11, 22, 26, 27].
Based on a sample of 10 umbilical cord units, we had
previously reported that under the same culture conditions,
MSC could be obtained from all 10 UC and, in contrast, from
only one UCB [11, 12]. In the present study, these results
were confirmed in a larger sampling, where MSC could be
obtained from all 65 UC and from only 6 UCB. They
support our previous observation on the importance of
banking the whole umbilical cord unit as a source of MSC.
Genomic studies have provided another dimension for a
detailed understanding of the MSC biology and ontogeny.
Several authors have analyzed the gene expression profile
of MSC, focusing mostly on three aspects: (i) changes
induced during in vitro differentiation to specific cell
lineages [46–50], (ii) direct comparison of gene expression
profiles in population of MSC obtained from several
sources [28–31, 45], and (iii) estimation of the absolute
expression levels in MSC [30, 32, 33]. However these
comparative studies were performed with different lineages
of MSC obtained from various sources and processed under
different conditions, which introduces many variables in the
analysis of global gene expression profiles. A systematic
comparison of the tissue expression signature of exonic and
intronic noncoding transcripts of MSC derived from related
sources and from match-paired samples analyzed under the
same culture conditions had not been described previously.
Intronic Noncoding Transcripts are Abundantly Expresses
in MSC from UC and UCB
We identified that 35% of all intronic noncoding transcripts
on the array were expressed in MSC from UC and UCB, as
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opposed to 80% of exonic protein-coding genes on the
array (Table 2). This reflects the fact that intronic non-
coding RNAs have tissue and cell-type specific expression
patterns, as demonstrated by our and other groups [34–38].
Interestingly, looking at the genomic loci of the most
highly expressed noncoding transcripts in MSC from UC,
the only statistically significant enriched GO categories
were those associated with genes involved with regulation
of transcription. The pattern found in MSC from umbilical
cord samples is similar to that already observed for kidney,
prostate and liver [37], emphasizing the importance of
noncoding RNAs in providing an additional layer of
regulatory functions in a number of different tissues [37,
51].
We also showed that both lineages of MSC share the
high expression of a considerable number of intronic
noncoding transcripts belonging to significantly enriched
shared functional categories such as Lymphoid Tissue
Structure and Development, Cellular Development and
Organ Development (Tables S5, S6, S7 and S8), which
supports a growing body of evidence in the literature
indicating that the noncoding RNAs are related to the
maintenance of pluripotency and the induction of alterna-
tive differentiation programs in stem cells [34]. Recently,
Efroni et al. [52] demonstrated widespread transcription in
protein-coding and noncoding regions in undifferentiated
embryonic stem cells, whereas the lineage specification is
driven by reduction of the transcribed portion of the
genome. Since the MSC from UCB and UC analyzed here
are undifferentiated and shared similar characteristics and
differentiation potential, it seems reasonable that the most
abundantly intronic expressed transcripts are, in fact,
common to most of the cells in the culture instead of being
expressed by a small subset of cells.
Nevertheless, the widespread expression of noncoding
RNAs in undifferentiated cells and during the differentia-
tion process support the hypothesis that these transcripts
enclose several functions related to stem cells biology and
therefore need to be considered to further understanding
several fundamental biological processes of development,
including ontogeny.
Exonic Protein-Coding Expression Profile in MSC
from UC Versus UCB
Comparative correlation coefficients of exonic protein-
coding expression profiles indicated that MSC from distinct
UC samples are more similar to each other than to their
UCB donor counterparts. In fact, MSC from different
tissues (UC versus UCB) did not cluster together, even in
paired MSC samples isolated from the same subject.
Previous studies comparing MSC obtained from unre-
lated individuals and different sources showed controversial
results; Wagner et al. [53] demonstrated significant differ-
ences in the global gene expression patterns of MSC from
adipose tissue, UCB and BM. Other studies have demon-
strated that MSC populations obtained from different
sources might exhibit significant differences in global
gene expression patterns that are likely related to their
differentiation capacities [3, 31, 54, 55]. On the other
hand, some authors have reported that the gene expression
profile of MSC of different sources were highly similar
[28, 45]. However, all these results should be regarded
with caution, because the expression analysis was based on
cell cultures obtained from different donors, and processed
by different methodologies that might explain, at least in
part, the observed diversity and/or similarity. Indeed, it had
been previously reported that culture conditions have a
significant impact on the gene expression profile [45].
Since the isolation of MSC is primarily based on
adherence to plastic and growth under specific culture
conditions, it is not surprising that culture media, the
number of passages and growth factors might play a
significant role in the selection of cell populations. To
exclude such variables, all our experiments were per-
formed in MSC isolated from the same donor, cultivated
under the same culture conditions and processed in the
same culture passage.
Despite that, our initial analysis using the entire set of
expressed protein-coding genes demonstrated a significant
difference in the exonic protein-coding transcript expres-
sion profiles of MSC from UC and UCB paired samples.
Therefore, we have focused on the differentially expressed
genes between them. Among the genes that were exclu-
sively over-expressed in UCB are osteopontin and osteo-
blast specific factor, which are involved in osteogenesis. In
fact, many of the integrin ligands implicated in the
adherence of osteoblasts to the extracellular matrix are
expressed at higher levels in MSC from UCB including
type XXI and XIV collagen and alpha 7 integrin [55]. Other
genes more expressed in UCB are EBF 1 and EBF 3,
recognized to be transcript factors related to development of
B-lymphoid cells [56]. Given that UCB could be represent-
ing the neonatal defense system against the earliest
encountered pathogens, it is not surprising that the genes
related to the immune system were over-expressed in MSC
from UCB.
Among the genes that were exclusively or expressed at
higher levels by MSC from UC is FLT1 (vascular
endothelial growth factor), a growth factor recognized to
be a main regulator of angiogenesis [55]. Other genes more
expressed in MSC from UC include SYNPO2, NRP2,
CDH2 and NPY [57–60]. All these genes could be related
to neurogenesis or synaptic transmission and regulation of
neurotransmitter secretion. In fact, the only significantly
enriched canonical pathway related to the genes over-
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expressed in MSC from UC was “Synaptic Long Term
Depression”, a pathway of neurophysiological processes. It
has been recently shown that MSC isolated from BM also
can express neuronal markers without induction [61, 62].
Alternatively, considering the anatomic position of BM, it is
possible that their stroma is innervated and contains nerve
terminals, which may be responsible for the expression of
neuron-related proteins [31]. In any case, it will be of great
interest to verify whether the differential expression of
some tissue specific genes in MSC from distinct sources
turns them more prone to differentiate into distinct cell
lines. For example, MSC from UC, in their undifferenti-
ated state, could be more appropriate for treatment of
neurodegenerative syndromes while MSC from UCB
could be more suitable for bone repair. In accordance to
these findings, recent functional studies in vivo have
indicated that MSC from UC may be therapeutically
useful in treating central nervous systems disorders,
which could be mediated by their ability to promote
angiogenesis and/or neurogenesis [63–66].
Although MSC of both origins are highly similar in the
noncoding transcript expression pattern, the differences in
their respective protein-coding gene expression profiles
might be due to the influence of the distinct local
environment in which they are located, reflecting the
importance of the niche in establishing the phenotype of
its residing stem cells [67]. Functional classification of
differentially expressed genes according to the Gene
Ontology categories has demonstrated an enrichment of
genes in the categories of development in UCB while cell
adhesion, morphogenesis, and secretion in UC. In order to
determine the role of individual genes on cell fate and
differentiation potential, additional functional studies will
be necessary and are currently underway.
Origin of MSC in Umbilical Cord Blood
Based on the technique used for cord blood harvesting, we
had previously suggested that MSC from UCB might be
derived from the umbilical cord tissue, which has been
shown to be an alternative source for MSC [11]. However,
results from the present study, demonstrating significant
differences in the global gene expression patterns of MSC
from UC and UCB paired samples, led us to suggest that
these cells are not the same. The origin of MSC in UCB,
however, remains to be elucidated.
Since the first report, several works have postulated that
multipotent stem cells are present in the perivascular niche of
various tissues [68]. The hypothesis that both hematopoietic
and MSC are travelling, via cord blood, from early fetal
hematopoietic sites to the newly formed bone marrow [24]
suggests that MSC from UCB might be derived from the
perivascular niche from fetal hematopoietic sites. The
observation that the quantity of MSC in UCB decreases
substantially with gestational age supports this hypothesis:
the highest concentration of progenitors was observed
during transition from hepatic to bone marrow hemato-
poiesis and the decline occurred with the termination of
this process at birth [69–72]. Furthermore, several lines of
evidence indicate that the MSC from UCB, liver and bone
marrow are similar to those present in adult bone marrow.
Despite the fact that MSC from UC and UCB are not the
same cells, they may share a common origin, such as the
perivascular niche.
The comparative gene expression profile observed in the
present study provides additional support to this hypothesis.
For example, the cluster analysis strongly indicates that
MSC from UC and UCB share a close relationship based on
the intronic noncoding transcripts, and this relationship may
reflect their common ontogeny and differentiation status. On
the other hand, clustering based on the protein-coding gene
expression profiles could indicate the activation of specific
sets of genes related to the tissue from which they were
isolated.
Conclusion
In conclusion, we demonstrated, for the first time, that the
intronic noncoding transcript expression patterns of MSC
from UCB and UC paired samples are highly similar,
suggesting that they share a common ontogeny and
differentiation status. We showed significant differences in
the protein-coding gene expression profile patterns of MSC
from UC and UCB paired samples. A set of genes related to
osteogenesis and immune systems was more expressed in
MSC from UCB, whereas higher expression in MSC from
UC tissue was observed for genes that participate in
pathways related to angiogenesis and neurogenesis. These
results suggest that MSC from a specific source may be
more efficient for a particular therapeutic target, which may
have important clinical implications. They reinforce our
previous suggestion on the importance of keeping the
whole umbilical cord unit by umbilical cord blood banks
for research or future therapeutic uses, in addition to
providing insight into MSC biology and ontogeny.
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